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Background
Interferon-beta (IFN-b) has both immuno-modulating
and anti-viral effects. In a longitudinal study of multiple
sclerosis (MS) patients undergoing interferon-beta ther-
apy, we have performed a comprehensive study of factors
in the innate and adaptive immune response to the two
types of virus associated with MS: human endogenous
retroviruses (HERVs), and herpesviruses.
Materials and methods
Anti-viral antibodies towards HERVs and herpesviruses
were assayed using TRIFMA or ELISA. Cytokine profil-
ing was performed using the Luminex-system. Factors in
the lectin complement activation pathway were assayed
using TRIFMA.
Results
We demonstrate significant decreases in anti-Envelope
antibody reactivity for the two closely related Gammare-
troviral HERVs, HERV-H and HERV-W, as a consequence
of IFN-b therapy, closely linked to efficacy of therapy/low
disease activity. We also found strong indications of a pro-
tective effect of high levels of two components in the
innate pathogen-associated molecular pattern recognition:
mannan-binding lectin (MBL), and MASP-3.
Serum levels of typical Th1- and Th2- related, MS-
relevant cytokines were also monitored. We found no
overall changes in Th1/Th2 ratios.
Conclusions
Our results support that IFN-b exerts effects on
immune response to HERV-H/HERV-W, and that this
antiviral response may play a role in MS development.
Components in the immune response to HERVs have
potential as biomarkers for disease activity.
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